The global hemostasis products market is poised for significant growth in the coming decade, according to the latest market projections. Valued at USD 1.58 billion in 2023, the market is anticipated ...

CEO Christopher Simon reported third-quarter revenue of $349 million, a 4% increase on a reported basis, with adjusted EPS rising 14% to $1.19. He highlighted the company's long-range plan driving ...